|
 |
SALT LAKE CITY, Utah –– March 3, 2010 –– BSD Medical Corporation (Nasdaq: BSDM) (“BSD or the “Company”), a leading developer and manufacturer of medical systems that treat cancer with heat therapy, today announced that it has retained Financial Profiles, Inc. to direct a comprehensive investor relations program.
“We are making solid progress expanding our product lines to offer a range of thermal systems in the United States and around the world for the treatment of cancer, including both hyperthermia and ablation treatment systems,” said Harold Wolcott, President of BSD. “It is time to communicate our progress and goals to a wider audience. Consistent with the addition of highly respected and accomplished executives to our management team in recent months, we have retained Financial Profiles to lead a proactive investor communications campaign.”
Financial Profiles will launch a series of initiatives to broaden the Company’s following with portfolio managers, analysts, stockbrokers and individual investors and to upgrade the Company’s scope and flow of investor information. Financial Profiles will also serve as the primary contact for communications with current and prospective shareholders.
“Led by a new, highly experienced senior management team, BSD is well-positioned for success with a large and growing global market opportunity, patented technology and existing and emerging product lines,” said Moira Conlon, Principal, Financial Profiles. “We are looking forward to building greater awareness of BSD’s business and growth strategies in the investment community.”
About Financial Profiles, Inc.
Financial Profiles is a communications consulting firm located in Los Angeles, California with expertise in investor relations and corporate and transaction communications. Financial Profiles has significant experience working with large public and small cap healthcare/medical device companies. Its solid foundation in business and communications enables the firm to create effective communications programs that help clients meet business objectives. The firm’s investor relations practice helps companies address valuation issues, communicate growth strategies to investors, and build Wall Street support. For more information, please visit www.finprofiles.com.
About BSD Medical Corporation
BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radio frequency (RF) and microwave energy. BSD’s product lines include both hyperthermia and ablation treatment systems. BSD’s hyperthermia cancer treatment systems, which have been in use for several years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. BSD’s microwave ablation system, which the Company will introduce to the market this year, has been developed as a stand-alone therapy to employ precision-guided microwave energy to ablate (remove or vaporize) soft tissue. The Company has extensive intellectual property, multiple products in the market and well established distribution in the United States, Europe and Asia. Certain of the Company’s products have received regulatory approvals in the United States, Europe and China. For further information visit BSD Medical\'s website at www.BSDMedical.com.
Forward-Looking Statements
Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company\\\'s filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.
|
|
|
